MbrlCatalogueTitleDetail

Do you wish to reserve the book?
AB0326 ELEVATED SERUM IL-10 IS ASSOCIATED WITH MYOINFLAMMATORY SYMPTOMS IN MIXED CONNECTIVE TISSUE DISEASE
AB0326 ELEVATED SERUM IL-10 IS ASSOCIATED WITH MYOINFLAMMATORY SYMPTOMS IN MIXED CONNECTIVE TISSUE DISEASE
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
AB0326 ELEVATED SERUM IL-10 IS ASSOCIATED WITH MYOINFLAMMATORY SYMPTOMS IN MIXED CONNECTIVE TISSUE DISEASE
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
AB0326 ELEVATED SERUM IL-10 IS ASSOCIATED WITH MYOINFLAMMATORY SYMPTOMS IN MIXED CONNECTIVE TISSUE DISEASE
AB0326 ELEVATED SERUM IL-10 IS ASSOCIATED WITH MYOINFLAMMATORY SYMPTOMS IN MIXED CONNECTIVE TISSUE DISEASE

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
AB0326 ELEVATED SERUM IL-10 IS ASSOCIATED WITH MYOINFLAMMATORY SYMPTOMS IN MIXED CONNECTIVE TISSUE DISEASE
AB0326 ELEVATED SERUM IL-10 IS ASSOCIATED WITH MYOINFLAMMATORY SYMPTOMS IN MIXED CONNECTIVE TISSUE DISEASE
Journal Article

AB0326 ELEVATED SERUM IL-10 IS ASSOCIATED WITH MYOINFLAMMATORY SYMPTOMS IN MIXED CONNECTIVE TISSUE DISEASE

2024
Request Book From Autostore and Choose the Collection Method
Overview
Background:Mixed connective tissue disease (MCTD) with a range of clinical manifestations and is recognized as an independent disease with similarities to systemic lupus erythematosus (SLE) and systemic sclerosis (SSc), or as an early manifestation of these conditions. In SLE, there is an imbalance in Th1/Th2 and Th17/Treg[1,2], activation of B cells in CD4+T cell subsets[3], and abnormal activation of CD4+T cells, as well as skin tissue infiltration and Th2/Th17 immune bias in SSc[4]. However, there is limited research on CD4+T cell subsets in MCTD, and the characteristics of these subsets are not well understood. Furthermore, cytokines such as IL-10 have been found to be closely associated with MCTD and play a significant role in its onset and progression.Objectives:We conducted an analysis of the peripheral blood lymphocyte subsets, CD4+T cell subsets, and related cytokines in these three disease groups and healthy controls in order to uncover the immune differences and characteristics between MCTD and SLE, SSc. Furthermore, we aimed to explore the relationship between the related cytokines IL-2 and IL-10 and MCTD.Methods:48 patients with MCTD, 51 patients with SLE, 35 patients with SSc and 49 with HCs were enrolled in this research. The absolute counts of peripheral blood lymphocyte subsets and CD4+T cell subsets were examined using flow cytometry, and serum cytokine levels were measured using flow cytometry microbead arrays.Results:Absolute counts of T cells, CD4+T cells, CD8+T cells, NK cells, Th1 cells, Th2 cells, and Treg cells were decreased in the MCTD group compared to the HC group (P<0.05). The absolute counts of CD4+T cells, Th1 cells, and Th2 cells were reduced in the MCTD group compared to the SSc group (P<0.05), and there was no significant difference compared to the SLE group. Cytokines (IL-2, IL-4, IL-6, IL-10, IL-17, IFN-γ, TNF-α) levels were significantly higher in the MCTD group compared to the HC group and the SSc group (P<0.05), and there was no significant difference in cytokines compared to the SLE group. Further analysis revealed that cardiac enzymes (CK, CK-MB, AST, α-HBDH, LDH) were positively correlated with cytokines (IL-2, IL-4, IL-6, IL-10, IL-17, IFN-γ, TNF-α) in MCTD (P<0.05). In addition, we found that IL-2 was associated with disease activity in MCTD and IL-10 was associated with myoinflammatory symptoms in MCTD, the area under the ROC curve (AUC) was 0.745 (95% CI 0.576-0.915, P=0.0116).Conclusion:Our investigation uncovered immunological variances in peripheral blood lymphocyte subgroups, CD4+T cell subgroups, and cytokines among MCTD, SLE, SSc, and healthy controls. Furthermore, we emphasized that cytokines in MCTD are linked with cardiac enzymes, and IL-2 is correlated with disease activity. IL-10 can serve as an autonomous risk factor and predictor of myoinflammatory symptoms in MCTD, laying the groundwork for further exploration into the potential pathogenesis of MCTD.REFERENCES:[1] Shan J, Jin H, Xu Y. T Cell Metabolism: A New Perspective on Th17/Treg Cell Imbalance in Systemic Lupus Erythematosus [J]. Front Immunol, 2020, 11: 1027.[2] Dolff S, Bijl M, Huitema M G, et al. Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus [J]. Clin Immunol, 2011, 141(2): 197-204.[3] Long D, Yang B, Yang M, et al. Bach2 in CD4(+) T cells from SLE patients modulates B-cell differentiation and IgG production [J]. Eur J Immunol, 2023, 53(4): e2250109.[4] Maehara T, Kaneko N, Perugino C A, et al. Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis [J]. Journal of Clinical Investigation, 2020, 130(5): 2451-2464.Acknowledgements:NIL.Disclosure of Interests:None declared.